Company intelligence / Profile preview

1,4Group

Meridian, Idaho, USA

Ownership: Private
Development stage: Other

Overview

1,4Group is an agricultural biotechnology company that specializes in post-harvest potato storage and dormancy management. The company is a pioneer in the development of 1,4-Dimethylnaphthalene (1,4-DMN), a naturally occurring plant regulator used to inhibit sprouting and maintain tuber quality. Their product line, including 1,4SIGHT and 1,4ZAP, provides the potato industry with effective alternatives to traditional synthetic sprout suppressants. In early 2024, the company was acquired by UPL, integrating its specialized portfolio into UPL's global post-harvest business unit, DECCO.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on 1,4Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1,4Group.

Explore the full profile